Europe Oligonucleotides Synthesis Market, By Product Type (Reagents and Consumables, Equipment, Synthesized Oligonucleotides, Oligonucleotide-based Drugs), Type (Custom Oligos, Predesigned Oligos), Application (Research, Therapeutic, Diagnostic, Others), End-User (Biotechnology and Pharmaceutical Companies, Research Institutes, Diagnostic Laboratories, Others), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2028
Market Analysis and Insights : Europe Oligonucleotides Synthesis Market
Data Bridge Market Research analyses that the Europe oligonucleotides synthesis market will account for USD 1,854.09 million by 2028 and grow at a CAGR of 13.6% in the forecast period of 2021-2028.
A single-stranded chain made up of a number of nucleoside units connected together by phosphodiester bridges is known as an oligonucleotide. The chemical synthesis of relatively small nucleic acid fragments is known as oligonucleotide synthesis. Synthetic oligonucleotides are frequently employed in treatments, research, and diagnostics. In life science research, oligonucleotides are employed as probe reagents and primers in DNA-based diagnostic test kits, as well as PCR and microarray-based reagents. These are being developed as direct treatments for a variety of disorders, including cancer and neurological diseases like Alzheimer's and Parkinson's.
The upsurge in the utilization of synthesized oligos among therapeutic applications and growing concentration on personalized medicines are the significant factors responsible for driving the growth of the oligonucleotides synthesis market. Additionally, the presence of better healthcare infrastructure and growing government funding synthetic biology and genome projects also heighten the market's overall growth. Likewise, other factors such as the significant increase in geriatric population, developments associated with purification and quality control technologies and the rising use of oligonucleotides by pharmaceutical companies will cushion the market growth rate.
Moreover, the rise in the number of research and development activities and the presence of major key players in emerging economies will generate profitable opportunities for the oligonucleotides synthesis market.
However, high cost associated with synthesized oligonucleotides and lack of skilled professionals will act as market restraints and obstruct the market's growth rate. Also, strict regulations and delivery of oligonucleotide drugs to specific targets will challenge the growth oligonucleotides synthesis market.
This Europe oligonucleotides synthesis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Europe oligonucleotides synthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Oligonucleotides Synthesis Market Scope and Market Size
Europe oligonucleotides synthesis market is segmented on the basis of product type, type, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the oligonucleotides synthesis market is segmented into reagents and consumables, equipment, synthesized oligonucleotides, oligonucleotide-based drugs. Synthesized oligonucleotides have been further sub-segmented into DNA oligonucleotides, RNA oligonucleotides and others.
- On the basis of type, the oligonucleotides synthesis market is segmented into custom oligos and predesigned oligos.
- On the basis of application, the oligonucleotides synthesis market is segmented into research, therapeutic, diagnostic and others. The research segment has been further sub-segmented into polymerase chain reaction, next generation sequencing and others. The therapeutic segment has been further sub-segmented into antisense oligonucleotides and nucleic acid aptamers.
- On the basis of end-user, the oligonucleotides synthesis market is segmented into biotechnology and pharmaceutical companies, research institutes, diagnostic laboratories and others.
Europe Oligonucleotides Synthesis Market Country Level Analysis
Europe oligonucleotides synthesis market is analysed and market size insights and trends are provided by country, product type, type, application and end-user as referenced above.
The countries covered in the Europe oligonucleotides synthesis market report are Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, and Rest of Europe.
The country section of the Europe oligonucleotides synthesis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The Europe oligonucleotides synthesis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe oligonucleotides synthesis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Europe oligonucleotides synthesis market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Europe Oligonucleotides Synthesis Market Share Analysis
Europe oligonucleotides synthesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe oligonucleotides synthesis market.
The major players covered in the Europe oligonucleotides synthesis market report are ATDBio Ltd., LGC Limited, GENERAL ELECTRIC, Merck KGaA, Ajinomoto Co., Inc., Agilent Technologies, Inc., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., Genscript, Danaher, LGC Biosearch Technologies, NITTO DENKO CORPORATION, Thermo Fisher Scientific Inc., TriLink BioTechnologies, PolyGen GmbH, Biolytic Lab Performance Inc., Quintara Biosciences, Bio Basic Inc., and Twist Bioscience, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-